The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.
about
Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic ReviewNext Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsDaclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-AnalysisGlobal epidemiology and burden of HCV infection and HCV-related disease.Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.Anti-hepatitis C virus seroprevalence in the working age population in Poland, 2004 to 2014Specific Age and Gender Prevalence of Hepatitis C Virus Infection in Iran.Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease BurdenHealthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan.Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients.Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.Real-world challenges for hepatitis C virus medications: a critical overview.Strategies to manage hepatitis C virus infection disease burden - volume 3.Lurking epidemic of hepatitis C virus infection in Iran: A call to action.Comment on Nuño Solinís R, et al. "Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence".Historical epidemiology of hepatitis C virus in select countries-volume 4.Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.Estimating HCV disease burden-volume 4 (editorial).Epidemiology and Elimination of HCV-Related Liver Disease
P2860
Q26745892-B5E347DC-161F-465C-8A54-3BA27B4799F1Q26747561-A978B898-4F6A-4427-8B10-DA3C861D81D0Q28077287-3F78A868-9C90-434A-BD99-BD624A3D15CEQ30240220-87915F28-3F1E-42D0-9FD2-8059D03C1F22Q30393824-C8F0B883-A101-439A-832F-B4D2AC3E6983Q33601691-629D3788-6A12-46A4-AE23-023CEA9A5D2FQ37102817-EED12832-1068-4F50-864F-077599A6CB15Q37189531-33EA9658-36AF-403A-9541-0B51742386DAQ37246465-EF2CDEFE-93BD-4948-B478-63B87F4D9447Q37543665-B05D9195-8E67-4C02-84A6-9AEB576A8D32Q38376454-41A5E643-8C91-4CAE-B34C-D6A822CBFE32Q38763789-6E401C43-9398-455A-99DA-03B88C7BBD88Q38838703-60E227E3-568F-4A7F-95F4-62077BA1435EQ38948620-243BE25C-5236-4729-B1A5-4527B16886E8Q39326974-BC708195-5371-4DAA-B112-3D34DE8FAA04Q40932583-D06C5DFD-4858-493C-AB00-37AF7384F034Q41608241-9A1B2CD9-4A77-4D05-9E14-EEB38C3320F7Q42345870-0C956F8C-91D9-4DF6-AA5A-70E13B875942Q45325255-F235A852-C97A-4BFD-9AA9-8BD3D787E2AEQ47197986-98A6C2B4-BB8B-45DC-9A46-602CDCC82ACEQ47547903-F63F17DD-E8FC-47AF-9D12-5948E94EF55BQ47589992-4BE7B039-7723-442F-9E04-BDADCA3CAD14Q57297223-E31E5692-15FE-4C61-91A2-605E4CD9F7AB
P2860
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The present and future disease ...... treatment paradigm - volume 3.
@en
type
label
The present and future disease ...... treatment paradigm - volume 3.
@en
prefLabel
The present and future disease ...... treatment paradigm - volume 3.
@en
P2093
P2860
P50
P356
P1476
The present and future disease ...... treatment paradigm - volume 3
@en
P2093
A A Aljumah
A Abourached
A Al Rifai
A Almessabi
A Chaudhry
A Ghafoor Khan
P2860
P356
10.1111/JVH.12476
P478
22 Suppl 4
P50
P577
2015-12-01T00:00:00Z